Cardinal Health (CAH) to Release Earnings on Thursday

Cardinal Health (NYSE:CAH) will likely be releasing its Q1 2026 results before the market opens on Thursday, October 30th. Analysts expect the company to announce earnings of $2.22 per share and revenue of $59.4086 billion for the quarter. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS.Investors can find conference call details on the company’s upcoming Q1 2026 earningreport page for the latest details on the call scheduled for Thursday, October 30, 2025 at 8:30 AM ET.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. During the same period in the previous year, the business earned $1.84 earnings per share. The firm’s quarterly revenue was up .5% compared to the same quarter last year. On average, analysts expect Cardinal Health to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $159.62 on Thursday. The company’s 50 day moving average price is $152.33 and its 200-day moving average price is $152.20. Cardinal Health has a 52-week low of $106.98 and a 52-week high of $168.44. The stock has a market capitalization of $37.92 billion, a price-to-earnings ratio of 24.75, a P/E/G ratio of 1.34 and a beta of 0.71.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s payout ratio is presently 31.63%.

Insider Transactions at Cardinal Health

In other news, insider Michelle D. Greene sold 13,500 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider owned 14,976 shares of the company’s stock, valued at $2,228,728.32. This represents a 47.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer owned 26,085 shares in the company, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 271,676 shares of company stock worth $40,489,525. Corporate insiders own 0.12% of the company’s stock.

Institutional Trading of Cardinal Health

Several institutional investors have recently added to or reduced their stakes in CAH. Integrated Wealth Concepts LLC boosted its holdings in Cardinal Health by 6.9% in the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after acquiring an additional 280 shares in the last quarter. Jones Financial Companies Lllp increased its stake in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new stake in shares of Cardinal Health during the 2nd quarter worth approximately $1,935,000. Cerity Partners LLC grew its stake in Cardinal Health by 17.0% in the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after purchasing an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC increased its holdings in Cardinal Health by 34.4% during the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after buying an additional 2,646 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Wells Fargo & Company reiterated an “overweight” rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a report on Tuesday, August 12th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $166.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.